BEYOND AIR INC. DL-0001
Beyond Air, Inc., a commercial-stage medical device and biopharmaceutical company, develops the Lungfit platform, a nitric oxide (NO) generator and delivery system platform. It operates through three segments: Beyond Air, Beyond Cancer, and NeuroNos. The company offers Lungfit PH for the treatment of persistent pulmonary hypertension of the newborn. It is also developing LungFit PRO for the treat… Read more
BEYOND AIR INC. DL-0001 (48L) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, BEYOND AIR INC. DL-0001 (48L) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
BEYOND AIR INC. DL-0001 - Net Assets Trend (None–None)
This chart illustrates how BEYOND AIR INC. DL-0001's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for BEYOND AIR INC. DL-0001 (None–None)
The table below shows the annual net assets of BEYOND AIR INC. DL-0001 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to BEYOND AIR INC. DL-0001's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
BEYOND AIR INC. DL-0001 Competitors by Market Cap
The table below lists competitors of BEYOND AIR INC. DL-0001 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
BPH Global Ltd
AU:BP8
|
$781.31K |
|
Grupo Vasconia S.A.B
MX:VASCONI
|
$781.57K |
|
American Pwr Group
PINK:APGI
|
$782.54K |
|
Planet Properindo Jaya Pt
JK:PLAN
|
$783.55K |
|
Uma Exports Limited
NSE:UMAEXPORTS
|
$780.88K |
|
Recreatives Industries Inc.
PINK:RECX
|
$780.78K |
|
Educomp Solutions Limited
NSE:EDUCOMP
|
$780.57K |
|
CHARLES SCHWAB - Dusseldorf Stock Exchang
DU:SWG
|
$780.35K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in BEYOND AIR INC. DL-0001's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares BEYOND AIR INC. DL-0001's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently BEYOND AIR INC. DL-0001 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares BEYOND AIR INC. DL-0001's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $253,026,393
- Average return on equity (ROE) among peers: -74.55%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| BEYOND AIR INC. DL-0001 (48L) | €- | N/A | N/A | $781.06K |
| HeraMED Limited (1I4) | $-105.98K | 0.00% | 0.00x | $17.10 Million |
| Q-linea AB (publ) (3F80) | $163.19 Million | -164.65% | 0.41x | $9.23 Million |
| Guerbet SA (4G8) | $342.14 Million | 13.51% | 1.79x | $44.77 Million |
| Scandinavian Real Heart AB (Publ) (7820) | $111.29 Million | -9.42% | 0.06x | $4.77 Million |
| aap Implantate AG (AAQ1) | $54.78 Million | 26.71% | 0.17x | $9.65 Million |
| Carmat SA (CXT) | $7.48 Million | -557.76% | 3.92x | $1.62 Million |
| elexxion AG (E8X) | $-0.01 | 0.00% | 0.00x | $199.10K |
| AETHLON MEDIC.NEW DL-001 (EJU) | $15.06 Million | -79.86% | 0.16x | $446.12K |
| Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) | $139.44 Million | 15.79% | 0.97x | $610.05 Million |
| Gaush Meditech Ltd (F7Y) | $1.70 Billion | 10.23% | 0.68x | $29.55 Million |